IDS and Mitral regurgitation: In this age group, uGAG levels were significantly reduced after 1, 2, and 3 years of IV idursulfase, and mitral valve regurgitation was improved or stabilized after 3 years of treatment; however, no significant improvements were reported for hepatosplenomegaly or JROM.